| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 475,141 | 528,897 | 554,178 | 565,839 | | Cost of Revenue | 132,294 | 162,113 | 162,614 | 155,545 | | | Gross Profit | 342,847 | 366,784 | 391,564 | 410,294 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 257,063 | 293,978 | 267,108 | 207,462 | | Non Recurring | 6,293 | 429,221 | 7,976 | 58,502 | | Others | 290,437 | 363,867 | 151,351 | 93,616 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (210,946) | (720,282) | (34,871) | 50,714 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (210,946) | (721,647) | (39,521) | 50,576 | | Interest Expense | 10,860 | 20,199 | 24,811 | 29,173 | | Income Before Tax | (221,806) | (741,846) | (64,332) | 21,403 | | Income Tax Expense | (85,077) | (106,436) | (24,211) | 9,304 | | Minority Interest |
-
| (1,365) | (4,650) | (138) | | | | Net Income From Continuing Ops | (136,729) | (635,410) | (40,121) | 12,099 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (136,729) | (635,410) | (40,121) | 12,099 | | Preferred Stock And Other Adjustments | (14,135) | (2,057) |
-
|
-
| | | Net Income Applicable To Common Shares | ($150,864) | ($637,467) | ($40,121) | $12,099 |
|
0.45% Nasdaq 
0.20%
Income Statement
